Quarterly ResultAug 4, 2026, 04:44 PM
LeMaitre Vascular Q2 Sales $70.4M (+10%), EPS $0.74 (+23%)
AI Summary
LeMaitre Vascular, Inc. reported strong preliminary financial results for Q2 2026, with sales increasing 10% to $70.4 million and diluted EPS rising 23% to $0.74. The company also announced a quarterly dividend of $0.25 per share and provided guidance for Q3 and the full year 2026. Key drivers included robust Artegraft sales and international expansion efforts, contributing to improved gross and operating margins.
Key Highlights
- Q2 2026 sales increased 10% to $70.4 million (10% organic growth).
- Diluted EPS for Q2 2026 rose 23% to $0.74.
- Gross margin improved by 210 bps to 72.1%; operating income grew 26% to $20.4 million.
- Cash and cash equivalents increased sequentially by $9.0 million to $376.2 million.
- Artegraft sales surged 34%; Grafts +23%, Carotid shunts +18%, Patches +4%.
- Board approved a quarterly dividend of $0.25/share, payable September 3, 2026.
- Provided Q3 2026 sales guidance of $66.3M-$68.3M and EPS of $0.66-$0.71.
- Full-year 2026 sales guidance set at $274.3M-$278.3M and EPS at $2.84-$2.94.
Price Impact
More from LMAT